Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
18.50
-0.20 (-1.07%)
At close: Jun 26, 2026, 4:00 PM EDT
18.72
+0.22 (1.20%)
After-hours: Jun 26, 2026, 7:43 PM EDT
Caris Life Sciences Market Cap
Caris Life Sciences has a market cap or net worth of $5.23 billion as of June 26, 2026.
Market Cap
5.23B
Enterprise Value
4.84B
1-Year Change
n/a
Ranking
Category
Stock Price
$18.50
Market Cap Chart
Since the IPO on June 18, 2025, Caris Life Sciences's market cap has decreased from $5.95B to $5.23B, a decrease of -12.18%. That is a compound annual growth rate of -11.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 5.23B | -31.30% |
| Dec 31, 2025 | 7.61B | 27.84% |
| Jun 18, 2025 | 5.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Belite Bio | 5.85B |
| Definium Therapeutics | 5.83B |
| Xenon Pharmaceuticals | 5.77B |
| Travere Therapeutics | 5.47B |
| Oruka Therapeutics | 5.46B |
| Legend Biotech | 5.33B |
| Veradermics | 5.30B |
| CRISPR Therapeutics AG | 5.30B |